News Announcement

Marksans Pharma: Unaudited Financial Results For The Quarter And Half-Year Ended 30Th September 2021 And Limited Review Reports Thereon

In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half-year ended 30th September 2021 which have been approved by the Board of Directors at its meeting held today i.e. 10th November 2021 along with Limited Review Reports given by statutory auditor of the Company.

The meeting commenced at 9:30 a.m. and concluded at 10:50 a.m.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.